Top compounds associated with response to MYO1F


Feature Type Standardized
Nominal ANOVA
mRNA Nilotinib GDSC1000 pan-cancer AAC 0.22 9e-08
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 1e-07
mRNA PF-573228 CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA foretinib CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA AZD6244 CCLE pan-cancer AAC 0.25 2e-07
mRNA FR-180204 GDSC1000 pan-cancer AAC 0.2 4e-07
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 6e-07
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.2 7e-07
Download CSV